- Home
- KALV vs MYI Comparison
KALV vs MYI Comparison
Compare KALV & MYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KALV
- MYI
- Stock Information
- Founded
- KALV N/A
- MYI 1992
- Country
- KALV United States
- MYI United States
- Employees
- KALV N/A
- MYI N/A
- Industry
- KALV Biotechnology: Pharmaceutical Preparations
- MYI Investment Bankers/Brokers/Service
- Sector
- KALV Health Care
- MYI Finance
- Exchange
- KALV Nasdaq
- MYI Nasdaq
- Market Cap
- KALV 651.3M
- MYI 723.2M
- IPO Year
- KALV N/A
- MYI N/A
- Fundamental
- Price
- KALV $12.92
- MYI $10.45
- Analyst Decision
- KALV Strong Buy
- MYI
- Analyst Count
- KALV 8
- MYI 0
- Target Price
- KALV $24.83
- MYI N/A
- AVG Volume (30 Days)
- KALV 498.7K
- MYI 256.7K
- Earning Date
- KALV 07-10-2025
- MYI 01-01-0001
- Dividend Yield
- KALV N/A
- MYI 4.81%
- EPS Growth
- KALV N/A
- MYI N/A
- EPS
- KALV N/A
- MYI N/A
- Revenue
- KALV N/A
- MYI N/A
- Revenue This Year
- KALV N/A
- MYI N/A
- Revenue Next Year
- KALV N/A
- MYI N/A
- P/E Ratio
- KALV N/A
- MYI N/A
- Revenue Growth
- KALV N/A
- MYI N/A
- 52 Week Low
- KALV $7.30
- MYI $9.32
- 52 Week High
- KALV $15.50
- MYI $11.70
- Technical
- Relative Strength Index (RSI)
- KALV 60.56
- MYI 45.11
- Support Level
- KALV $11.11
- MYI $10.37
- Resistance Level
- KALV $11.93
- MYI $10.51
- Average True Range (ATR)
- KALV 0.60
- MYI 0.10
- MACD
- KALV 0.05
- MYI -0.00
- Stochastic Oscillator
- KALV 80.09
- MYI 44.19
About KALV KalVista Pharmaceuticals Inc.
KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema; and oral plasma kallikrein inhibitors. Geographically it operates throughout the region of the United States. The company is also conducting preclinical development on a novel, oral, Factor XIIa inhibitor program.
About MYI Blackrock MuniYield Quality Fund III Inc
BLACKROCK MUNIYIELD QUALITY FUND III, INC. is a investment management company. Its investment objective is to provide shareholders with a high level of current income exempt from U.S. federal income taxes as is consistent with its investment policies and prudent investment management. The company invests in various sectors such as Transportation; Utilities; Health; Education; Tobacco and others.